Y0403180 | 双时相低精蛋白锌重组人胰岛素注射液 | | Injection | Biological Products(15) | Generic Drug | 2004-05-12 | 江苏万邦生化医药股份有限公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2004-10-15 | view |
Y0403179 | 双时相低精蛋白锌重组人胰岛素注射液 | | Injection | Biological Products(15) | Generic Drug | 2004-05-12 | 江苏万邦生化医药股份有限公司 | Wanbang Biopharmaceuticals | Certificate Issued | 2004-10-15 | view |
JYSZ0700032 | 精蛋白锌重组人胰岛素注射液 | Protamine Zinc Recombinant Human Insulin | Injection | Biological Products | License Renew | 2007-11-06 | Lilly Deutschland GmbH | Lilly Deutschland GmbH | Certificate Issued | 2010-03-30 | view |
JYSB2000529 | 精蛋白锌重组人胰岛素注射液 | Protamine Zinc Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2020-10-22 | Lilly France | Lilly France | In Review | 2020-10-21 | view |
JYSB2000528 | 精蛋白锌重组人胰岛素注射液 | Protamine Zinc Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2020-10-22 | Lilly France | Lilly France | In Review | 2020-10-21 | view |
JYSB2000506 | 精蛋白锌重组人胰岛素注射液 | Protamine Zinc Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2020-10-13 | Lilly France | Lilly France | Certificate Issued | 2020-11-26 | view |
JYSB2000505 | 精蛋白锌重组人胰岛素注射液 | Protamine Zinc Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2020-10-13 | Lilly France | Lilly France | Certificate Issued | 2020-11-26 | view |
JYSB2000440 | 精蛋白锌重组人胰岛素注射液 | Protamine Zinc Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2020-09-08 | Lilly France | Lilly France | Filed | 2020-09-18 | view |
JYSB2000439 | 精蛋白锌重组人胰岛素注射液 | Protamine Zinc Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2020-09-08 | Lilly France | Lilly France | Filed | 2020-09-18 | view |
JYSB2000263 | 精蛋白锌重组人胰岛素注射液 | Protamine Zinc Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2020-06-18 | Lilly France | Lilly France | Filed | 2020-06-22 | view |
JYSB2000262 | 精蛋白锌重组人胰岛素注射液 | Protamine Zinc Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2020-06-18 | Lilly France | Lilly France | Filed | 2020-06-22 | view |
JYSB2000261 | 精蛋白锌重组人胰岛素注射液 | Protamine Zinc Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2020-06-18 | Lilly France | Lilly France | Filed | 2020-06-22 | view |
JYSB2000260 | 精蛋白锌重组人胰岛素注射液 | Protamine Zinc Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2020-06-18 | Lilly France | Lilly France | Filed | 2020-06-22 | view |
JYSB1900183 | 精蛋白锌重组人胰岛素注射液 | Protamine Zinc Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2019-07-26 | Lilly France | Lilly France | Certificate Issued | 2019-11-01 | view |
JYSB1900182 | 精蛋白锌重组人胰岛素注射液 | Protamine Zinc Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2019-07-22 | Lilly France | Lilly France | Certificate Issued | 2019-11-01 | view |
JYSB1900181 | 精蛋白锌重组人胰岛素注射液 | Protamine Zinc Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2019-07-22 | Lilly France | Lilly France | Certificate Issued | 2019-11-01 | view |
JYSB1900180 | 精蛋白锌重组人胰岛素注射液 | Protamine Zinc Recombinant Human Insulin | Injection | Biological Products | Supplementary Application | 2019-07-26 | Lilly France | Lilly France | Certificate Issued | 2019-11-01 | view |
JYSB1900034 | 精蛋白锌重组人胰岛素注射液(预混50R) | | Injection | Biological Products | Supplementary Application | 2019-01-18 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2020-02-17 | view |
JYSB1900033 | 精蛋白锌重组人胰岛素注射液(预混50R) | | Injection | Biological Products | Supplementary Application | 2019-01-23 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2020-02-17 | view |
JYSB1900025 | 精蛋白锌重组人胰岛素注射液(预混30R) | | Injection | Biological Products | Supplementary Application | 2019-01-17 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2020-02-17 | view |